Medical Dosimetry Program at the University of Wisconsin, La Crosse, 1725 State St, La Crosse, WI 54601, USA.
Medical Dosimetry Program at the University of Wisconsin, La Crosse, 1725 State St, La Crosse, WI 54601, USA.
Med Dosim. 2020;45(2):121-127. doi: 10.1016/j.meddos.2019.08.001. Epub 2019 Sep 27.
Decreasing radiotoxicity to the heart, lungs, and contralateral breast has proven to lower the risk of secondary malignancy and improve overall outcomes when treating chest wall (CW) and regional lymph nodes in postmastectomy breast cancer patients. In this retrospective study, 11 postmastectomy patients were selected and planned with a novel hybrid treatment method and a traditional volumetric arc therapy (VMAT) approach for comparison. This hybrid technique was able to optimize tangential beams to minimize heart dose and the VMAT contribution to improve dose conformity around the planning target volume (PTV). Overall, this hybrid technique produced more homogenous target dose coverage and demonstrated a decrease of integral dose to organs at risk (OAR), while the VMAT technique demonstrated a higher affinity for maintaining dose conformity. Further observation of dose distributions also revealed that the hybrid plans were more effective in sparing low-dose spread to healthy tissue in both right- and left-sided cases. This observation was made evident by the reduction in heart V5 and D, decreases in all parameters regarding the contralateral lung, as well as all values other than the V20 of the ipsilateral lung. This unique hybrid planning technique could present an alternative to standard intensity-modulated radiation therapy (IMRT) planning when treating postmastectomy CW and regional lymph nodes, as it has shown the capacity to decrease cardiac, lung, and contralateral breast toxicity while maintaining quality PTV coverage.
降低心脏、肺和对侧乳房的放射性毒性已被证明可以降低乳腺癌根治术后胸壁 (CW) 和区域淋巴结治疗中继发性恶性肿瘤的风险,并改善整体预后。在这项回顾性研究中,选择了 11 例乳腺癌根治术后患者,分别采用新的混合治疗方法和传统的容积弧形治疗 (VMAT) 方法进行计划比较。这种混合技术能够优化切线束以最小化心脏剂量,VMAT 技术的贡献则可以改善计划靶区 (PTV) 周围的剂量一致性。总体而言,这种混合技术可以更好地实现靶区剂量均匀覆盖,并减少危及器官 (OAR) 的积分剂量,而 VMAT 技术则更有利于保持剂量一致性。进一步观察剂量分布还表明,混合计划在保护右侧和左侧病例的健康组织免受低剂量照射方面更有效。这一观察结果通过降低心脏 V5 和 D、降低所有与对侧肺相关的参数以及除同侧肺的 V20 之外的所有值得到了证实。这种独特的混合计划技术在治疗乳腺癌根治术后 CW 和区域淋巴结时,可以替代标准调强放疗 (IMRT) 计划,因为它已显示出降低心脏、肺和对侧乳房毒性的能力,同时保持高质量的 PTV 覆盖。